Acquiring Company
Advanced Instruments
Acquired Company
Nova Biomedical
BiotechnologyHealth CareManufacturing
Description
Advanced Instruments has announced a definitive agreement to acquire Nova Biomedical, leading to a merger that will create a global life science tools platform under the Nova Biomedical name. The transaction aims to enhance the combined company’s capabilities in the biopharma and clinical markets. Closing is expected in the third quarter of 2025, pending regulatory approval.
M&A Insights
Based on deal dataIntegration timeline
70% of M&A integrations take 12-24 months to complete
Tech stack consolidation
83% of merged companies consolidate technology vendors within first year
Post-acquisition investment
Companies increase IT spending by 23% on average after acquisitions
Success factor
M&A deals with strong technology integration plans are 2.5x more likely to succeed